<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:hpo ids='HP_0001655'>Patent foramen ovale</z:hpo> (<z:mp ids='MP_0004225'>PFO</z:mp>) can be diagnosed by contrast-enhanced transcranial Doppler (cTCD), but no definitive criteria exist to correlate the results obtained from cTCD with diagnoses of <z:mp ids='MP_0004225'>PFO</z:mp> obtained by contrast-enhanced transesophageal echocardiography (cTEE) </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the present study was to analyze markers in the positive RLS by cTCD that confirm the <z:mp ids='MP_0004225'>PFO</z:mp> by cTEE </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Twenty-six <z:hpo ids='HP_0001297'>stroke</z:hpo> patients who had previously submitted to cTEE, 16 with <z:mp ids='MP_0004225'>PFO</z:mp> (<z:mp ids='MP_0004225'>PFO</z:mp> group) and 10 without <z:mp ids='MP_0004225'>PFO</z:mp> (no-<z:mp ids='MP_0004225'>PFO</z:mp> group), were evaluated for three markers based on a positive cTCD test </plain></SENT>
<SENT sid="3" pm="."><plain>The number of microembolic signs (<z:chebi fb="28" ids="39005,39010">MES</z:chebi>), the latency time (LT) to the first <z:chebi fb="28" ids="39005,39010">MES</z:chebi> and the duration time (DT) of <z:chebi fb="28" ids="39005,39010">MES</z:chebi> were evaluated to look for a difference between the <z:mp ids='MP_0004225'>PFO</z:mp> and no-<z:mp ids='MP_0004225'>PFO</z:mp> group </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The <z:mp ids='MP_0004225'>PFO</z:mp> group had higher <z:chebi fb="28" ids="39005,39010">MES</z:chebi> (80.9+/-124.5 vs. 10.2+/-25.6, p&lt;0.001), shorter LT (12.5+/-6.6 vs. 16.2+/-5.1, p=0.02) and longer DT (21.4+/-17.4 vs. 11.7+/-12.5, p=0.013) compared with the no-<z:mp ids='MP_0004225'>PFO</z:mp> group </plain></SENT>
<SENT sid="5" pm="."><plain>Considering only <z:chebi fb="70" ids="34342">MCA</z:chebi> tests with more than 9 MES and LT shorter than 9s, 30% of patients from the <z:mp ids='MP_0004225'>PFO</z:mp> group had positive tests compared with no patients from the no-<z:mp ids='MP_0004225'>PFO</z:mp> group </plain></SENT>
<SENT sid="6" pm="."><plain>This cutoff demonstrates a specificity and positive predictive value of 100% </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The rule of nine (&gt;9 MES and LT &lt;9s) for cTCD can be considered a marker for <z:mp ids='MP_0004225'>PFO</z:mp> diagnosis by cTEE </plain></SENT>
</text></document>